Improving Control of Gene Therapy-Based Neurotrophin Delivery for Inner Ear Applications

Background: Survival and integrity of the spiral ganglion is vital for hearing in background noise and for optimal functioning of cochlear implants. Numerous studies have demonstrated that supplementation of supraphysiologic levels of the neurotrophins BDNF and NT-3 by pumps or gene therapy strategies supports spiral ganglion survival. The endogenous physiological levels of growth factors within the inner ear, although difficult to determine, are likely extremely low within the normal inner ear. Thus, novel approaches for the long-term low-level delivery of neurotrophins may be advantageous. Objectives: This study aimed to evaluate the long-term effects of gene therapy-based low-level neurotrophin supplementation on spiral ganglion survival. Using an adenovirus serotype 28-derived adenovector delivery system, the herpes latency promoter, a weak, long expressing promoter system, has been used to deliver the BDNF or NTF3 genes to the inner ear after neomycin-induced ototoxic injury in mice. Results: Treatment of the adult mouse inner ear with neomycin resulted in acute and chronic changes in endogenous neurotrophic factor gene expression and led to a degeneration of spiral ganglion cells. Increased survival of spiral ganglion cells after adenoviral delivery of BDNF or NTF3 to the inner ear was observed. Expression of BDNF and NT-3 could be demonstrated in the damaged organ of Corti after gene delivery. Hearing loss due to overexpression of neurotrophins in the normal hearing ear was avoided when using this novel vector–promoter combination. Conclusion: Combining supporting cell-specific gene delivery via the adenovirus serotype 28 vector with a low-strength long expressing promoter potentially can provide long-term neurotrophin delivery to the damaged inner ear.

[1]  D. Wedekind,et al.  Expression pattern of brain-derived neurotrophic factor and its associated receptors: Implications for exogenous neurotrophin application , 2020, Hearing Research.

[2]  M. Shew,et al.  Evaluating Neurotrophin Signaling Using MicroRNA Perilymph Profiling in Cochlear Implant Patients With and Without Residual Hearing , 2021, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[3]  D. Brough,et al.  Hearing Preservation Following Repeated Adenovector Delivery , 2020, Anatomical record.

[4]  P. Leake,et al.  AAV-Mediated Neurotrophin Gene Therapy Promotes Improved Survival of Cochlear Spiral Ganglion Neurons in Neonatally Deafened Cats: Comparison of AAV2-hBDNF and AAV5-hGDNF , 2019, Journal of the Association for Research in Otolaryngology.

[5]  H. Staecker,et al.  Detection of BDNF-Related Proteins in Human Perilymph in Patients With Hearing Loss , 2019, Front. Neurosci..

[6]  P. Leake,et al.  Virally Mediated Overexpression of Glial-Derived Neurotrophic Factor Elicits Age- and Dose-Dependent Neuronal Toxicity and Hearing Loss. , 2019, Human gene therapy.

[7]  B. Wilson The cochlear implant and possibilities for narrowing the remaining gaps between prosthetic and normal hearing , 2017, World journal of otorhinolaryngology - head and neck surgery.

[8]  M. Blumer,et al.  Role of BDNF and neurotrophic receptors in human inner ear development , 2017, Cell and Tissue Research.

[9]  A. Dabdoub,et al.  Cochlear Implants Meet Regenerative Biology: State of the Science and Future Research Directions. , 2017, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[10]  H. Benav,et al.  NANOCI—Nanotechnology Based Cochlear Implant With Gapless Interface to Auditory Neurons , 2017, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[11]  Y. Raphael,et al.  Neurotrophin Gene Therapy in Deafened Ears with Cochlear Implants: Long-term Effects on Nerve Survival and Functional Measures , 2017, Journal of the Association for Research in Otolaryngology.

[12]  A. Kral,et al.  Encapsulated cell device approach for combined electrical stimulation and neurotrophic treatment of the deaf cochlea , 2017, Hearing Research.

[13]  S. Plontke,et al.  Intracochlear drug delivery in combination with cochlear implants , 2016, HNO.

[14]  Min Young Lee,et al.  Viral-mediated Ntf3 overexpression disrupts innervation and hearing in nondeafened guinea pig cochleae , 2016, Molecular therapy. Methods & clinical development.

[15]  L. Gillespie,et al.  Firing frequency and entrainment maintained in primary auditory neurons in the presence of combined BDNF and NT3 , 2016, Scientific Reports.

[16]  Ning Zhou,et al.  Importance of cochlear health for implant function , 2015, Hearing Research.

[17]  Y. Raphael,et al.  Differential Effects of AAV.BDNF and AAV.Ntf3 in the Deafened Adult Guinea Pig Ear , 2015, Scientific Reports.

[18]  M. Liberman,et al.  Neurotrophin-3 regulates ribbon synapse density in the cochlea and induces synapse regeneration after acoustic trauma , 2014, eLife.

[19]  D. Brough,et al.  Optimizing atoh1‐induced vestibular hair cell regeneration , 2014, The Laryngoscope.

[20]  S. Green,et al.  Postnatal Expression of Neurotrophic Factors Accessible to Spiral Ganglion Neurons in the Auditory System of Adult Hearing and Deafened Rats , 2014, The Journal of Neuroscience.

[21]  J. Nadol,et al.  Within-Subject Comparison of Word Recognition and Spiral Ganglion Cell Count in Bilateral Cochlear Implant Recipients , 2014, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[22]  M. Knipper,et al.  The function of BDNF in the adult auditory system , 2014, Neuropharmacology.

[23]  Alexander M. Hetherington,et al.  Effects of Brain-Derived Neurotrophic Factor (BDNF) and Electrical Stimulation on Survival and Function of Cochlear Spiral Ganglion Neurons in Deafened, Developing Cats , 2013, Journal of the Association for Research in Otolaryngology.

[24]  A. Wise,et al.  Neurotrophin Gene Therapy for Sustained Neural Preservation after Deafness , 2012, PloS one.

[25]  S. Green,et al.  The Trk A, B, C's of Neurotrophins in the Cochlea , 2012, Anatomical record.

[26]  H. Versnel,et al.  Neurotrophins and their role in the cochlea , 2012, Hearing Research.

[27]  M. Frotscher,et al.  Jcb: Article , 2022 .

[28]  O. Akil,et al.  Cochlear gene therapy. , 2012, Current opinion in neurology.

[29]  H. Rask-Andersen,et al.  Expression of TrkB and BDNF in human cochlea—an immunohistochemical study , 2011, Cell and Tissue Research.

[30]  M. Liberman,et al.  Nonneuronal cells regulate synapse formation in the vestibular sensory epithelium via erbB-dependent BDNF expression , 2010, Proceedings of the National Academy of Sciences.

[31]  C. Jolly,et al.  Cochlear implantation: an opportunity for drug development. , 2010, Drug discovery today.

[32]  D. Brough,et al.  Adenovector-mediated hair cell regeneration is affected by promoter type , 2010, Acta oto-laryngologica.

[33]  Z. Rusznák,et al.  Spiral ganglion neurones: an overview of morphology, firing behaviour, ionic channels and function , 2009, Pflügers Archiv - European Journal of Physiology.

[34]  D. Brough,et al.  Alternate serotype adenovector provides long-term therapeutic gene expression in the eye , 2008, Molecular vision.

[35]  Y. Raphael,et al.  Over-expression of BDNF by adenovirus with concurrent electrical stimulation improves cochlear implant thresholds and survival of auditory neurons , 2008, Hearing Research.

[36]  S. Soekadar,et al.  BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls. , 2007, Journal of psychiatric research.

[37]  M. Liberman,et al.  Dynamic patterns of neurotrophin 3 expression in the postnatal mouse inner ear , 2007, The Journal of comparative neurology.

[38]  D. Brough,et al.  Vestibular Hair Cell Regeneration and Restoration of Balance Function Induced by Math1 Gene Transfer , 2007, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[39]  T. Stöver,et al.  Differential brain-derived neurotrophic factor and transforming growth factor-beta expression in the rat cochlea following deafness , 2006, Neuroreport.

[40]  J. Glorioso,et al.  Long-term neuroprotection achieved with latency-associated promoter-driven herpes simplex virus gene transfer to the peripheral nervous system. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[41]  M. Liberman,et al.  Influence of Supporting Cells on Neuronal Degeneration After Hair Cell Loss , 2005, Journal of the Association for Research in Otolaryngology.

[42]  U. Zimmermann,et al.  Lack of Bdnf and TrkB signalling in the postnatal cochlea leads to a spatial reshaping of innervation along the tonotopic axis and hearing loss , 2003, Development.

[43]  M. Hansen,et al.  Reciprocal signaling between spiral ganglion neurons and Schwann cells involves neuregulin and neurotrophins , 2001, Hearing Research.

[44]  A. Davies,et al.  Selective Regulation of trkC Expression by NT3 in the Developing Peripheral Nervous System , 1999, The Journal of Neuroscience.

[45]  Thomas R. Van De Water,et al.  Brain-derived neurotrophic factor gene therapy prevents spiral ganglion degeneration after hair cell loss , 1998, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[46]  I. Ferrer,et al.  BDNF Up‐Regulates TrkB Protein and Prevents the Death of CA1 Neurons Following Transient Forebrain Ischemia , 1998, Brain pathology.

[47]  A. Kay,et al.  Trophic Support of Cultured Spiral Ganglion Neurons by Depolarization Exceeds and Is Additive with that by Neurotrophins or cAMP and Requires Elevation of [Ca2+]i within a Set Range , 1997, The Journal of Neuroscience.

[48]  J. Graham,et al.  Cochlear implantation , 1995, BMJ.

[49]  G. Moonen,et al.  Neurotrophins affect survival and neuritogenesis by adult injured auditory neurons in vitro. , 1994, Neuroreport.